Invitation to Annual General Meeting of Shareholders
Active Biotech AB is a biotechnology company focusing on research in and development of pharmaceuticals. Active Biotech has a strong R&D portfolio and pipeline products with focus primarily on autoimmune/inflammatory diseases and cancer. Most advanced projects include orally administered small molecules with unique immunomodulatory properties that can be used to treat autoimmune and inflammatory diseases (SAIK), as well as a novel concept for use in cancer immunotherapy (TTS).
Invitation to Annual General Meeting of Shareholders in Active Biotech AB (publ)
The shareholders in Active Biotech AB (publ) are hereby invited to attend the Annual General Meeting of Shareholders to be held at 17.00 on Thursday, 10 April 2003 at Edison Park, Emdalavägen 16 in Lund.
Shareholders, who wish to participate in the Annual General Meeting of Shareholders, must
both be entered under their own names (not registered as a trustee) in the register of shareholders maintained by Värdepapperscentralen VPC AB on behalf of the Company, as of Monday, 31 March 2003,
and notify the Company of their intention to participate in the Annual General Meeting of Shareholders by no later than 4 pm on Friday, 4 April 2003.
Notification of participation in the Annual General Meeting of Shareholders shall be made in writing to Active Biotech AB (publ), Att: Susanne Jönsson, P.O. Box 724, SE-220 07 Lund, by telephone on +46 (0)46 19 20 00, by telefax on +46 (0)46 19 20 50 or via e-mail to firstname.lastname@example.org
. Upon notification the following information shall be provided: name, personal identity number/corporate registration number, address and telephone number, together with numbers and type(s) of shares.
In order to possess the right to participate in the Annual General Meeting of Shareholders, shareholders whose shares are registered in trust through a bank's trust department or individual stockbroker, must temporarily register the shares with VPC in their own name. Such re-registration must be completed by no later than Monday, 31 March 2003.